11 results on '"Jun Tao HU"'
Search Results
2. Biotransformation of 1,8-Dihydroxyanthraquinone into Peniphenone under the Fermentation of Aleurodiscus mirabilis
- Author
-
Ya-Xian Shi, Le Cai, Li Zhu, Zhong-Tao Ding, Jun-Li Gan, Sheng-Qi Zhang, Rui-Feng Mei, and Jun-Tao Hu
- Subjects
chemistry.chemical_classification ,Oxidase test ,General Chemical Engineering ,General Chemistry ,Article ,chemistry.chemical_compound ,Metabolic pathway ,Dihydroxyanthraquinone ,Polyketide ,Chemistry ,Enzyme ,Biochemistry ,chemistry ,Biotransformation ,Fermentation ,Emodin ,QD1-999 - Abstract
The present study verified that 1,8-dihydroxyanthraquinone (1), a common component in some industrial raw materials and dyes, could be converted into peniphenone (2), which possesses immunosuppressive activity and other medicinal potential, by Aleurodiscus mirabilis fermentation. The yield of peniphenone (2) after 7 days of fermentation was 11.05 ± 2.19%. To reveal the transformation mechanism, two secondary metabolites, emodin (3) and monodictyphenone (4), were isolated from the fermentation broth of A. mirabilis, implying that polyketide metabolic pathways from emodin (3) to monodictyphenone (4) might exist in A. mirabilis. 1,8-Dihydroxyanthraquinone (1) was suspected to be converted into peniphenone (2) via the same pathway since emodin (3) and 1,8-dihydroxyanthraquinone (1) share very similar skeletons. The P450 enzyme and Baeyer-Villiger oxidase in A. mirabilis were confirmed to catalyze this biotransformation on the basis of ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) analysis. This novel investigation could shed light on the mechanism and therefore development of peniphenone production from 1,8-dihydroxyanthraquinone by microbial fermentation.
- Published
- 2020
3. Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol
- Author
-
Jie Zhang, Bang-De Xiang, Jian-Hong Zhong, Liang Ma, Jun Tao Huang, Wen Feng Gong, and Le Qun Li
- Subjects
Medicine - Abstract
Introduction Current clinical guidelines recommend systematic antitumour therapy as the primary treatment option for patients with stage IIIb hepatocellular carcinoma (HCC) based on the China liver cancer (CNLC) staging criteria. Several different targeted therapeutics have been applied in combination with immunotherapeutic regimens to date in patients with advanced HCC. The present study was developed to evaluate the relative safety and efficacy of hepatectomy of HCC in combination with targeted apatinib treatment and immunotherapeutic camrelizumab treatment CNLC-IIIb stage HCC patients with the goal of providing evidence regarding the potential value of this therapeutic regimen in individuals diagnosed with advanced HCC.Methods and analysis This is a multicentre phase II trial with single-arm in which patients undergo hepatectomy in combination with targeted treatment (apatinib) and immunotherapy (camrelizumab). Patients will undergo follow-up every 2–3 months following treatment initiation to record any evidence of disease progression and adverse event incidence for a minimum of 24 months following the discontinuation of treatment until reaching study endpoint events or trial termination. The primary endpoint for this study is patient mortality.Ethics and dissemination This study protocol was approved by the Ethics Committee of the Guangxi Medical University Cancer Hospital (KS2022[124]). The results of this study will be submitted for publication in a peer-reviewed journal.Trial registration number NCT05062837.
- Published
- 2023
- Full Text
- View/download PDF
4. The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials
- Author
-
Liang Yan Jiang, Wei Zhou, Jun Tao Hu, Chi Zhang, Zhan Hong Tang, Shou Zhen Wang, and Xianfeng Chen
- Subjects
medicine.medical_specialty ,medicine.drug_class ,Epidemiology ,Antibiotics ,medicine.disease_cause ,Daptomycin ,Internal medicine ,medicine ,Humans ,Adverse effect ,Randomized Controlled Trials as Topic ,business.industry ,Incidence (epidemiology) ,Research ,Soft Tissue Infections ,General Medicine ,Bacterial Infections ,Skin Diseases, Bacterial ,Surgery ,Discontinuation ,Anti-Bacterial Agents ,Infectious Diseases ,Treatment Outcome ,Staphylococcus aureus ,Meta-analysis ,Vancomycin ,business ,medicine.drug - Abstract
Objective Daptomycin, a cyclic lipopeptide that exhibits rapid, concentration-dependent bactericidal activity in vitro against a broad spectrum of Gram-positive pathogens, has now, since 2003, been approved in more than 70 countries and regions to treat skin and soft-tissue infections (SSTIs). The purpose of this meta-analysis was to compare the safety and efficacy of daptomycin with other antibiotics, especially with vancomycin which has long been considered the standard therapy for complicated SSTIs. Design Meta-analysis of randomised controlled trials (RCTs). Data sources We thoroughly searched PubMed, EMBASE, Cochrane Central to identify relevant RCTs. Six RCTs with a total of 1710 patients were included in this meta-analysis. Results The results demonstrated that the efficacy of daptomycin was at par with or maybe better than other first-line antibiotics for treating SSTIs as shown by the OR for clinical success (OR=1.05, 95% CI 0.84 to 1.31, p=0.65, I2=0%); daptomycin versus vancomycin subgroup (OR=1.19, 95% CI 0.77 to 1.83, p=0.43, I2=0%); overall microbiological success (OR=1.05, 95% CI 0.61 to 1.79, p=0.86, I2=42%); microbiological success of daptomycin versus comparators for Staphylococcus aureus (SA, OR=1.05, 95% CI 0.61 to 2.60, p=0.53, I2=47%), for methicillin-resistant S. aureus (OR=0.90, 95% CI 0.77 to 1.06, p=0.20, I2=56%). However, daptomycin tended to have a similar treatment-related adverse events (AEs) incidence in comparison with other antibiotics (OR=1.06, 95% CI 0.71 to 1.59, p=0.76, I2=41%). The trend showed that daptomycin might cause less discontinuation due to AEs and death compared with other first-line antibiotics (OR=0.71, 95% CI 0.46 to 1.10, p=0.12, I2=11%). Significantly more patients in the daptomyicn group had creatine phosphokinase elevation than those in the control group; however, it could be reversed when the therapy ended (OR=1.95, 95% CI 1.04 to 3.65, p=0.04, I2=0). Conclusions This meta-analysis demonstrated that the safety and efficacy of daptomycin was not inferior to that of other first-line drugs, and daptomycin tended to exhibit superior efficacy when compared with vancomycin or with comparators for SA infections; nevertheless, more high-quality RCTs are needed to draw a more credible conclusion.
- Published
- 2014
5. Raman Studies on Species in Single and Mixed Solutions of Molybdate and Vanadate.
- Author
-
Jia-liang Zhang, Jun-tao Hu, and Li-feng Zhang
- Abstract
Raman spectroscopy was applied to investigate the speciation in both single and mixed solutions of molybdate and vanadate at pH values from 10.0 to 1.0. Evidence was obtained for the difference of existing forms between these two elements. Vanadium mainly exists as (VO
3 )n n- while Mo is MoO4 2- in the pH range of 9.0-7.5. This difference is the theoretical basis for many available separation process. The species in the binary system was identified by comparing the Raman spectra with that in the single systems. Molybvanadates are formed below pH=6.5, which may partly be ascribed to the replacement of V atoms by Mo atoms in some V-O-V groups. Vanadium mainly exists as the decavanadate species in the pH range of 6.0-2.0. The predominant species of Mo are heteropolyanions having structural features of heptamolybdate rather than Mo8 O26 4- and Mo36 O112 8- which are the predominant Mo species in single solution at pH=2.0-1.0. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
6. Thermal plasticity is related to the hardening response of heat shock protein expression in two Bactrocera fruit flies.
- Author
-
Jun-tao Hu, Bing Chen, and Zhi-hong Li
- Subjects
- *
GENE expression , *INSECT genetics , *PHENOTYPIC plasticity , *HARDENING (Heat treatment) , *HEAT shock proteins , *BACTROCERA , *INTRODUCED species - Abstract
It is generally believed that widely distributed species differ in their thermal plasticity from narrowly distributed species, but how differences in thermal plasticity are regulated at the molecular level remains largely unknown. Here, we conducted a comparative study of two closely related invasive fruit fly species, Bactrocera correcta and Bactrocera dorsalis, in China. The two species had overlapping distributions, but B. dorsalis had a much wider range throughout the country and a longer invasive history than B. correcta. We first examined the effects of thermal acclimation on the ability of the two fruit flies to survive heat stress. The heat shock tolerance of B. dorsalis was significantly enhanced by heat hardening at 35, 37, 39 and 41°C, but that of B. correcta was only enhanced by heat hardening at 39°C and 41°C. Thus, the more widespread species has a higher thermal plasticity than the narrowly distributed species. We then determined the expression of Hsp70 and Hsp90 during different developmental stages and their responses to thermal hardening. The expression of both Hsp70 and Hsp90 in larvae was upregulated in response to heat hardening, starting at 35°C for B. dorsalis and at 39°C for B. correcta. The two species exhibited a highly consistent pattern of thermal response in terms of their heat shock survival rates and levels of Hsp gene expression. The results suggest that the difference in thermal plasticity may be responsible for the different distributions of the two species and that Hsp expression may be involved in the regulation of thermal plasticity. Our findings have important implications for the prediction of the thermal limits and ecological responses of related species in nature. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
7. The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials.
- Author
-
Shou Zhen Wang, Jun Tao Hu, Chi Zhang, Wei Zhou, Xian Feng Chen, Liang Yan Jiang, and Zhan Hong Tang
- Abstract
Objective: Daptomycin, a cyclic lipopeptide that exhibits rapid, concentration-dependent bactericidal activity in vitro against a broad spectrum of Gram-positive pathogens, has now, since 2003, been approved in more than 70 countries and regions to treat skin and soft-tissue infections (SSTIs). The purpose of this meta-analysis was to compare the safety and efficacy of daptomycin with other antibiotics, especially with vancomycin which has long been considered the standard therapy for complicated SSTIs. Design: Meta-analysis of randomised controlled trials (RCTs). Data sources: We thoroughly searched PubMed, EMBASE, Cochrane Central to identify relevant RCTs. Six RCTs with a total of 1710 patients were included in this meta-analysis. Results: The results demonstrated that the efficacy of daptomycin was at par with or maybe better than other first-line antibiotics for treating SSTIs as shown by the OR for clinical success (OR=1.05, 95% CI 0.84 to 1.31, p=0.65, I
2 =0%); daptomycin versus vancomycin subgroup (OR=1.19, 95% CI 0.77 to 1.83, p=0.43, I2 =0%); overall microbiological success (OR=1.05, 95% CI 0.61 to 1.79, p=0.86, I2 =42%); microbiological success of daptomycin versus comparators for Staphylococcus aureus (SA, OR=1.05, 95% CI 0.61 to 2.60, p=0.53, I2 =47%), for methicillin-resistant S. aureus (OR=0.90, 95% CI 0.77 to 1.06, p=0.20, I2 =56%). However, daptomycin tended to have a similar treatment-related adverse events (AEs) incidence in comparison with other antibiotics (OR=1.06, 95% CI 0.71 to 1.59, p=0.76, I2 =41%). The trend showed that daptomycin might cause less discontinuation due to AEs and death compared with other first-line antibiotics (OR=0.71, 95% CI 0.46 to 1.10, p=0.12, I2 =11%). Significantly more patients in the daptomyicn group had creatine phosphokinase elevation than those in the control group; however, it could be reversed when the therapy ended (OR=1.95, 95% CI 1.04 to 3.65, p=0.04, I2 =0). Conclusions: This meta-analysis demonstrated that the safety and efficacy of daptomycin was not inferior to that of other first-line drugs, and daptomycin tended to exhibit superior efficacy when compared with vancomycin or with comparators for SA infections; nevertheless, more high-quality RCTs are needed to draw a more credible conclusion. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
8. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
- Author
-
De-Li Dong, Chang Chen, Rong Huo, Ning Wang, Zhe Li, Yu-Jie Tu, Jun-Tao Hu, Xia Chu, Wei Huang, Bao-Feng Yang, Dong, De-Li, Chen, Chang, Huo, Rong, Wang, Ning, Li, Zhe, Tu, Yu-Jie, Hu, Jun-Tao, Chu, Xia, Huang, Wei, and Yang, Bao-Feng
- Abstract
Cardiac hypertrophy involves a remodeling process of the heart in response to diverse pathological stimuli. Both calcineurin/nuclear factor of activated T cells pathway and microRNA-133 (miR-133) have been shown to play a critical role in cardiac hypertrophy. It has been recognized that the expression and activity of calcineurin increases and miR-133 expression decreases in the hypertrophic heart, and inhibition of calcineurin or increase of miR-133 expression protects against cardiac hypertrophy. Here we tested the interaction between miR-133 and calcineurin in cardiac hypertrophy. Cardiac hypertrophy in vivo and in vitro was induced by transverse aortic constriction and phenylephrine treatment. mRNA levels were measured by using real-time PCR methods. Luciferase assays showed that transfection of miR-133 in HEK293 cells downregulated calcineurin expression, which was reversed by cotransfection with the miR-133-specific 2'-O-methyl antisense inhibitory oligoribonucleotides. These results were confirmed in cultured primary cardiomyocytes. miR-133 expression was downregulated, and calcineurin activity was enhanced in both in vivo and in vitro cardiac hypertrophy models. Treatment of cells and animals with cyclosporin A, an inhibitor of calcineurin, prevented miR-133 downregulation. Moreover, the antisense oligodeoxynucleotides against the catalytic subunits of calcineurin Abeta and the decoy oligodeoxynucleotides targeting nuclear factor of activated T cells transcription factor, a calcineurin downstream effector, increased miR-133 expression in cultured primary cardiomyocytes. Our data show that reciprocal repression between miR-133 and calcineurin regulates cardiac hypertrophy. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
9. Inhibition of 2-Aminoethoxydiphenyl Borate-induced Rat Atrial Ectopic Activity by Anti-arrhythmic Drugs.
- Author
-
Rong Huo, Zhe Li, Cui-Cui Lu, Yan Xie, Bin Wang, Yu-Jie Tu, Jun-Tao Hu, Chang-Qing Xu, Bao-Feng Yang, and De-Li Dong
- Subjects
BORATES ,HEART atrium ,CARDIOVASCULAR agents ,HEART cells ,LABORATORY rats ,CARDIAC research - Abstract
Background/Aims: 2-aminoethoxydiphenyl borate (2-APB) provokes spontaneous mechanical activity in isolated rat left atria. The present study is to characterize 2-APB-induced ectopic activity in rat atria and to investigate the inhibition of 2-APB-induced ectopic activity by anti-arrhythmic drugs. Methods: 2-APB-induced ectopic activity was measured through an isometric force transducer connected to a multichannel acquisition and analysis system. Intracellular [Ca
2+ ]i was measured with fluorescence laser scanning confocal microscopy. Voltage-dependent L- type Ca2+ currents were recorded by using patch-clamp technique. Results: 2-APB dose-dependently increased the ectopic activity of left atria at 1, 5, 10, 20, 50 μM. Anti-arrhythmic drugs, quinidine (10μM), lidocaine (10μM), verapamil (5μM), and amiodarone (50μM,100μM) inhibited 2-APB-induced ectopic activity. 2-APB-induced ectopic activity was inhibited by Ca2+ -free bath, Na+ /Ca2+ exchanger blockers, 3′,4′-dichlorobenzamil hydrochloride (DHC) and Ni2+ , not by non-selective cation channel blocker Gd3+ . 2-APB also induced ectopic contractions in ventricular tissue straps and the ectopic contractions were inhibited by quinidine, verapamil and DHC. Lidocaine, verapamil and DHC inhibited 2-APB-induced increase of intracellular Ca2+ concentration in cardiomyocytes. Low molecular weight heparin inhibited phenylephrine (PE)-induced but not 2-APB -induced atria ectopic activity, and the pattern of 2-APB-induced ectopic activity was continuous, distinct from the discontinuous activity induced by PE. Conclusion: 2-APB-induced atria ectopic activity was inhibited by classic anti-arrhythmic drugs quinidine, lidocaine, verapamil, amiodarone, and Na+ /Ca2+ exchanger blockers. It can be used for testing agents able to affect any of Na+ , Ca2+ channel, Na+ /Ca2+ exchanger without selectivity. Copyright © 2010 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
10. The synthesis of one-dimensional controllable ZnO microrods.
- Author
-
Lin-Li, Zhang, Chang-Xin, Guo, Jian-Gang, Chen, and Jun-Tao, Hu
- Published
- 2005
- Full Text
- View/download PDF
11. Preparation and Luminescent Properties of ZnO Microrods and Microtubes.
- Author
-
Jian-Gang, Chen, Chang-Xin, Guo, Lin-Li, Zhang, and Jun-Tao, Hu
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.